Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
about
Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugsDiffusion-weighted imaging in cancer: physical foundations and applications of restriction spectrum imaging.Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging.Advances in neuro-oncology imaging.Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques.Effect of disease and recovery on functional anatomy in brain tumor patients: insights from functional MRI and diffusion tensor imaging.Pretreatment ADC Values Predict Response to Radiosurgery in Vestibular Schwannomas.Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas.The Added Prognostic Value of Metabolic Tumor Size on FDG-PET at First Suspected Recurrence of Glioblastoma Multiforme.Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma.Diffusion Weighted/Tensor Imaging, Functional MRI and Perfusion Weighted Imaging in Glioblastoma-Foundations and Future.Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG).
P2860
Q28082603-CA316A65-A9EB-49B2-8DF2-36D6D70F1432Q30847288-E37480B3-1329-459F-8033-A18B1DF64DF6Q35771783-522622C2-FDFC-413B-89A1-004E3D075B11Q36279879-4DBB6A1C-8E5F-409F-B98D-38B7368D3F1DQ36339461-F8E8CE7A-BAC1-4DE1-BD85-5F5CE3DA9772Q36618214-26C83625-C163-4C81-9AB2-68CF06163147Q37649351-D6A5E364-1CEB-4D8E-A5C0-C1408161B19DQ38837570-56B653F5-EFBD-433A-913B-CF56C1AFD0C9Q41120949-7927BFC1-1CD2-485B-9E2A-3C24E88E1362Q47281917-CD2D43E6-4090-4952-8065-489C915150E6Q48318624-28A22333-602D-4D8B-828A-D1CE0D41E710Q49274965-C87BC1A2-C43C-4F42-8123-8680B4790CBAQ49566176-3B8E1C2C-8763-46CD-A8DB-735FE833046C
P2860
Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Can MRI-derived factors predic ...... rative chemoradiation therapy?
@ast
Can MRI-derived factors predic ...... rative chemoradiation therapy?
@en
Can MRI-derived factors predic ...... rative chemoradiation therapy?
@nl
type
label
Can MRI-derived factors predic ...... rative chemoradiation therapy?
@ast
Can MRI-derived factors predic ...... rative chemoradiation therapy?
@en
Can MRI-derived factors predic ...... rative chemoradiation therapy?
@nl
prefLabel
Can MRI-derived factors predic ...... rative chemoradiation therapy?
@ast
Can MRI-derived factors predic ...... rative chemoradiation therapy?
@en
Can MRI-derived factors predic ...... rative chemoradiation therapy?
@nl
P2093
P2860
P356
P1433
P1476
Can MRI-derived factors predic ...... rative chemoradiation therapy?
@en
P2093
Hideo Nakamura
Mika Kitajima
Toshinori Hirai
Yasuyuki Yamashita
P2860
P304
P356
10.1258/AR.2012.120525
P407
P577
2012-11-08T00:00:00Z